ClinicalTrials.gg
CompletedNCT05898555Updated Oct 6, 2026

Validation of Smart Garments for Gait Classification

An observational study in Healthy, sponsored by Myant Medical Corp.. Completed at 1 site in Canada. Open to participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Myant Medical Corp. · Observational

How we know

Updated Oct 6, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years to 64 Years
Sex
All
01

Study summary

The aim of this study is therefore to validate Myant SKIIN garments for the purpose of gait and balance assessment. To achieve this, we recruit young healthy adults from the University of Waterloo to wear Skiin products (see Fig. 1). Participants will be asked to perform a number of scripted gait and balance tasks.

Read the detailed description

Specific objectives of this study are:

  1. To validate Skiin gait characterization algorithm (based on single garment solutions - already developed based on a literature and a previous study conducted at the University of Waterloo);
  2. To develop algorithms for multi-garments solutions that aim to extract additional kinematic parameters such as joint angles.

Gait metrics from Skiin garments will be compared to metrics from a gold standard measurement (Vicon motion capture) to indicate accuracy, precision and reliability.

02

Conditions studied

  • Healthy

Keywords

  • Gait analysis
  • Wearable electronic devices
03

In context

Lead sponsor

Myant Medical Corp. is the lead sponsor of 7 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

A convenience-sample of 20 healthy individuals will be recruited for this study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Healthy male and female adults aged 18y - 64y old

Exclusion criteria

Exclusion Criteria:

- Self-reported lower limb conditions, neurological disorders, history of concussion/brain trauma, and/or condition limiting exercise is to mitigate additional risk for injury and/or adverse reactions associated with exercise.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthy individuals

    Gait study protocol

    Device: Skiin garment and pods

Interventions

  • DeviceSkiin garment and pods

    Participants will be asked to wear a Skiin smart garment over their own clothes. Small motion capture markers will be placed on their body and pressure-sensitive insoles placed into their shoes to measure the pressure underneath their feet during the study tasks. Once the sensors are ready for collection, participants will be asked to complete 5 tasks associated with their daily activities: 1. Locomotion; 2. Lower limb strength - repeated sit-to-stand-to-sit transitions; 3. Lower limb strength and locomotion - Timed Up and Go; 4. Free walking during a 2min walk; 5. Standing balance, postural control.

06

What researchers measure

Primary outcomes

  1. Error in step length metric

    The difference between step lengths calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  2. Error in stride length metric

    The difference between stride length calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  3. Error in cadence metric

    The difference between cadence calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  4. Error in step duration (s) metric, and its asymmetry

    The difference between step duration (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  5. Error in stride duration (s) metric, and its asymmetry

    The difference between stride duration (s), and its asymmetry calculated from Skiin data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  6. Error in stance duration (s) metric, and its asymmetry

    The difference between stance duration (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  7. Error in swing duration (s) metric, and its asymmetry

    The difference between swing duration(s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  8. Error in initial double support (s) metric, and its asymmetry

    The difference between double support (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  9. Error in terminal double support (s) metric, and its asymmetry

    The difference between terminal double support (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  10. Error in double support (s) metric, and its asymmetry

    The difference between double support (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  11. Error in single limb support (s) metric, and its asymmetry

    The difference between single limb support (s), and its asymmetry calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  12. Error in gait speed metric

    The difference between gait speed calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  13. Error in stride speed metric

    The difference between stride speed calculated from Skiin data and from Vicon data for each scripted gait tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  14. Error in mean CoM sway distance

    The difference between sway distance of the Center of mass calculated from Skiin data and from Vicon data for each scripted balance tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  15. Error in mean CoM sway velocity

    The difference between sway velocity of the Center of mass calculated from Skiin data and from Vicon data for each scripted balance tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  16. Error in CoM sway area

    The difference between sway area of the Center of mass calculated from Skiin data and from Vicon data for each scripted balance tasks.

    Time frame: Collection during the single study session of 1.5 hours.

  17. Error in CoM sway frequency

    The difference between sway frequency of the Center of mass calculated from Skiin data and from Vicon data for each scripted balance tasks.

    Time frame: Collection during the single study session of 1.5 hours.

07

Study locations

1 site
  • University of Waterloo - Engineering 7
    Waterloo, Ontario N2L3G1, Canada
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from May 2023 to primary completion in Sep 2023, 3 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: primary completion May 2024 → Sep 2023 and completion Jun 2024 → Mar 2024.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 1, 2023
First posted
Jun 12, 2023
StartActual
May 26, 2023
Primary completionActual
Sep 18, 2023was May 2024
CompletionActual
Mar 14, 2024was Jun 2024
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 6, 2026
Primary completion
May 1, 2024→Sep 18, 2023 (actual)
Oct 6, 2026
Study completion
Jun 30, 2024→Mar 14, 2024 (actual)
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    Recruiting→Completed
    Primary completion May 1, 2024→Sep 18, 2023 (now actual)
    Study completion Jun 30, 2024→Mar 14, 2024 (now actual)
    + 3 other changes: criteria formatting, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05898555
Lead sponsor
Myant Medical Corp.
Collaborators
University of Waterloo
Responsible party
Sponsor
First posted
Jun 12, 2023
Start date
May 26, 2023
Primary completion
Sep 18, 2023
Completion
Mar 14, 2024
Last update
Oct 6, 2026

Study contacts

James Tung, PhD
principal investigator · University of Waterloo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion